ag-1296 and bromodeoxyuridine

ag-1296 has been researched along with bromodeoxyuridine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Enjoji, M; Iwamoto, H; Nakamuta, M; Nawata, H; Sugimoto, R; Tada, S1

Other Studies

1 other study(ies) available for ag-1296 and bromodeoxyuridine

ArticleYear
Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth.
    The Journal of laboratory and clinical medicine, 2000, Volume: 135, Issue:5

    Topics: Animals; Becaplermin; Blotting, Western; Bromodeoxyuridine; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Isoenzymes; Liver; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phospholipase C gamma; Phosphorylation; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Proto-Oncogene Proteins p21(ras); Rats; Rats, Wistar; Receptor, Platelet-Derived Growth Factor beta; Type C Phospholipases; Tyrphostins

2000